Helicobacter pylori eradication for gastric cancer prevention

Journal of Gastroenterology

Volumn 42, Issue SUPPL.17, 2007, Pages 10-15

  Cheung, Ting Kin ^a   Xia, Harry H X ^a   Wong, Benjamin C Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Atrophic gastritis; Eradication; Gastric cancer; Helicobacter pylori; Intestinal metaplasia

Indexed keywords

AMOXICILLIN; ASCORBIC ACID; BETA CAROTENE; CLARITHROMYCIN; CLAVULANATE POTASSIUM; METRONIDAZOLE; OMEPRAZOLE; PLACEBO;

ARTICLE; ASIA; ATROPHIC GASTRITIS; CANCER INCIDENCE; CANCER PREVENTION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; EARLY INTERVENTION; ERADICATION THERAPY; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; INTESTINE METAPLASIA; LONG TERM CARE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RISK FACTOR; STOMACH CANCER; STOMACH CARCINOGENESIS;

ANTI-BACTERIAL AGENTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STOMACH NEOPLASMS;

EID: 33846456598     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-006-1939-2     Document Type: Article

References (60)

1. CJ Murray AD Lopez 1997 Mortality by cause for eight regions of the world: Global Burden of Disease Study Lancet 349 1269-76 9142060 10.1016/ S0140-6736(96)07493-4 1:STN:280:ByiB1cnps1w%3D
2. P Pisani F Bray DM Parkin 2002 Estimates of the world-wide prevalence of cancer for 25 sites in the adult population Int J Cancer 97 72-81 11774246 10.1002/ijc.1571 1:CAS:528:DC%2BD3MXovFKrurk%3D
3. J Ferlay F Bray P Pisani D Parkin 2001 Globocan 2000: Cancer incidence, mortality, and prevalence worldwide. Version 1.0. IARC Cancer Base No. 5 IARC Press Lyon
4. BC Wong SK Lam CK Ching WH Hu E Kwok J Ho 1999 Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China. China Gastric Cancer Study Group J Gastroenterol Hepatol 14 120-5 10029291 10.1046/j.1440-1746.1999.01823.x 1:STN:280:DyaK1M7ltFOnuw%3D%3D
5. GD Eslick LL Lim JE Byles HH Xia NJ Talley 1999 Association of Helicobacter pylori infection with gastric carcinoma: A meta-analysis Am J Gastroenterol 94 2373-9 10483994 10.1111/j.1572-0241.1999.01360.x 1:STN:280:DyaK1MvhtFOqtw%3D%3D
6. P Limburg Y Qiao S Mark G Wang G Perez-Perez M Blaser 2001 Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China J Natl Cancer Inst 93 226-33 11158192 10.1093/jnci/ 93.3.226 1:STN:280:DC%2BD3M7ot1Kgsw%3D%3D
7. EM El-Omar K Oien LS Murray A El-Nujumi A Wirz D Gillen 2000 Increased prevalence of precancerous changes in relatives of gastric cancer patients: Critical role of H. pylori Gastroenterology 118 22-30 10611150 10.1016/S0016-5085(00)70410-0 1:STN:280:DC%2BD3c%2FnvFWitA%3D%3D
8. N Uemura S Okamoto S Yamamoto N Matsumura S Yamaguchi M Yamakido 2001 Helicobacter pylori infection and the development of gastric cancer N Engl J Med 345 784-9 11556297 10.1056/NEJMoa001999 1:STN:280:DC%2BD3MrgslCqtA%3D%3D
9. H Brenner G Bode H Boeing 2000 Helicobacter pylori infection among offspring of patients with stomach cancer Gastroenterology 118 31-5 10611151 10.1016/S0016-5085(00)70411-2 1:STN:280:DC%2BD3c%2FnvFWitQ%3D%3D
10. T Watanabe M Tada H Nagai S Sasaki M Nakao 1998 Helicobacter pylori infection induces gastric cancer in Mongolian gerbils Gastroenterology 115 642-8 9721161 10.1016/S0016-5085(98)70143-X 1:STN:280:DyaK1czoslynsA%3D%3D
11. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. In: IARC monographs on the evaluation of carcinogenic risks to humans. IARC Monograph 1994;61:177-241 177-241
12. P Correa 1992 Human gastric carcinogenesis: A multistep and multifactorial process - first American Cancer Society award lecture on cancer epidemiology and prevention Cancer Res 52 6735-40 1458460 1:CAS:528:DyaK3sXjs1Orsw%3D%3D
13. HH Xia JS Kalantar NJ Talley JM Wyatt S Adams K Chueng 2000 Antral-type mucosa in the gastric incisura, body, and fundus (antralization): A link between Helicobacter pylori infection and intestinal metaplasia? Am J Gastroenterol 95 114-21 10638568 10.1111/j.1572-0241.2000.01609.x 1:STN:280:DC%2BD3c7gt1WjtA%3D%3D
14. HH Xia GS Zhang NJ Talley BC Wong Y Yang C Henwood 2002 Topographic association of gastric epithelial expression of Ki-67, Bax, and Bcl-2 with antralization in the gastric incisura, body, and fundus Am J Gastroenterol 97 3023-31 12492185 10.1111/j.1572-0241.2002.07120.x 1:CAS:528:DC%2BD3sXhtl2rsA%3D%3D
15. HH Xia Y Yang SK Lam WM Wong SY Leung ST Yuen 2004 Aberrant epithelial expression of trefoil family factor 2 and mucin 6 in Helicobacter pylori infected gastric antrum, incisura, and body and its association with antralisation J Clin Pathol 57 861-6 15280409 10.1136/jcp.2003.015487 1:CAS:528:DC%2BD2cXnsVagtLk%3D
16. CJ Schorah GM Sobala M Sanderson N Collis JN Primrose 1991 Gastric juice ascorbic acid: Effects of disease and implications for gastric carcinogenesis Am J Clin Nutr 53 1 Suppl 287S-93S 1985400 1:STN:280:By6D1M%2Fgt1w%3D
17. S Banerjee C Hawksby S Miller S Dahill AD Beattie KE McColl 1994 Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid Gut 35 317-22 8150339 1:STN:280:ByuB3c%2FmsFE%3D
18. ZW Zhang SE Patchett D Perrett P Domizio MJ Farthing 2000 Gastric alpha-tocopherol and beta-carotene concentrations in association with Helicobacter pylori infection Eur J Gastroenterol Hepatol 12 497-503 10833091 1:CAS:528:DC%2BD3cXjvVemtrY%3D
19. GR Davies NJ Simmonds TR Stevens MT Sheaff N Banatvala IF Laurenson 1994 Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo Gut 35 179-85 8307467 1:STN:280:ByuC2c%2FitlU%3D
20. HH Xia BC Wong 2003 Nitric oxide in Helicobacter pylori -induced apoptosis and its significance in gastric carcinogenesis J Gastroenterol Hepatol 18 1227-30 14535977 10.1046/j.1440-1746.2003.03147.x
21. HH Xia 1998 Association between Helicobacter pylori and gastric cancer: current knowledge and future research World J Gastroenterol 4 93-6
22. NL Jones PT Shannon E Cutz H Yeger PM Sherman 1997 Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection Am J Pathol 151 1695-703 9403720 1:STN:280:DyaK1c%2FmsF2kug%3D%3D
23. RJ Cahill H Xia C Kilgallen S Beattie H Hamilton C O'Morain 1995 Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation Dig Dis Sci 40 1627-31 7648960 10.1007/BF02212681 1:STN:280:ByqA2sjgs1M%3D
24. SF Moss J Calam B Agarwal S Wang PR Holt 1996 Induction of gastric epithelial apoptosis by Helicobacter pylori Gut 38 498-501 8707076 1:STN:280:BymA3sjhsVI%3D
25. Y Yang CS Deng JZ Peng BC Wong SK Lam HH Xia 2003 Effect of Helicobacter pylori on apoptosis and apoptosis related genes in gastric cancer cells Mol Pathol 56 19-24 12560457 10.1136/mp.56.1.19 1:CAS:528:DC%2BD3sXhs1yntr8%3D
26. HH Xia BC Yu Wong NJ Talley SK Lam 2002 Alternative and rescue treatment regimens for Helicobacter pylori eradication Expert Opin Pharmacother 3 1301-11 12186623 10.1517/14656566.3.9.1301 1:CAS:528:DC%2BD38XmvF2mtLg%3D
27. J Parsonnet RA Harris HM Hack DK Owens 1996 Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: A mandate for clinical trials Lancet 348 150-4 8684154 10.1016/ S0140-6736(96)01501-2 1:STN:280:BymB1MrivFE%3D
28. AM Fendrick ME Chernew RA Hirth BS Bloom RR Bandekar JM Scheiman 1999 Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer Arch Intern Med 159 142-8 9927096 10.1001/archinte.159.2.142 1:STN:280:DyaK1M7isVartA%3D%3D
29. P Roderick R Davies J Raftery D Crabbe R Pearce P Patel 2003 Cost-effectiveness of population screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation J Med Screen 10 148-56 14561268 10.1258/096914103769011067 1:STN:280:DC%2BD3svotlGlsw%3D%3D
30. RM Genta GM Lew DY Graham 1993 Changes in the gastric mucosa following eradication of Helicobacter pylori Mod Pathol 6 281-9 8346176 1:STN:280:ByyA2cfhsFY%3D
31. EM Witteman M Mravunac MJ Becx WP Hopman JS Verschoor GN Tytgat 1995 Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori J Clin Pathol 48 250-6 7730488 1:STN:280:ByqB2cjpt1w%3D
32. GM Forbes JR Warren ME Glaser DJ Cullen BJ Marshall BJ Collins 1996 Long-term follow-up of gastric histology after Helicobacter pylori eradication J Gastroenterol Hepatol 11 670-3 8840244 1:STN:280:BymH3sjlvFM%3D
33. J Ciok J Dzieniszewski C Lucer 1997 Helicobacter pylori eradication and antral intestinal metaplasia - two years follow-up study J Physiol Pharmacol 48 Suppl 4 115-22 9440062
34. RW van der Hulst A van der Ende FW Dekker FJ Ten Kate JF Weel JJ Keller 1997 Effect of Helicobacter pylori eradication on gastritis in relation to cagA: A prospective 1-year follow-up study Gastroenterology 113 25-30 9207258 10.1016/S0016-5085(97)70076-3 1:STN:280:ByiA2M%2FovVY%3D
35. N Uemura T Mukai S Okamoto S Yamaguchi H Mashiba K Taniyama 1997 Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer Cancer Epidemiol Biomarkers Prev 6 639-42 9264278 1:STN:280:ByiH3cjlt10%3D
36. A Tucci L Poli C Tosetti G Biasco W Grigioni O Varoli 1998 Reversal of fundic atrophy after eradication of Helicobacter pylori Am J Gastroenterol 93 1425-31 9732919 10.1111/j.1572-0241.1998.00454.x 1:STN:280:DyaK1cvgtFOmtw%3D%3D
37. K Satoh K Kimura T Takimoto K Kihira 1998 A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori Helicobacter 3 236-40 9844064 1:STN:280:DyaK1M%2Fmt1Smsw%3D%3D
38. B Tepes B Kavcic LK Zaletel M Gubina A Ihan M Poljak 1999 Two- to four-year histological follow-up of gastric mucosa after Helicobacter pylori eradication J Pathol 188 24-9 10398136 10.1002/ (SICI)1096-9896(199905)188:1<24::AID-PATH316>3.0.CO;2-F 1:STN:280:DyaK1MzlvFGltQ%3D%3D
39. J Kyzekova J Mour 1999 The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study Hepatogastroenterology 46 2048-56 10430396 1:CAS:528:DyaK1MXkvFKhu7w%3D
40. B Annibale MR Aprile G D'Ambra P Caruana C Bordi G Delle Fave 2000 Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia Aliment Pharmacol Ther 14 625-34 10792127 10.1046/j.1365-2036.2000.00752.x 1:STN:280:DC%2BD3c3lt1OgsQ%3D%3D
41. JJ Sung SR Lin JY Ching LY Zhou KF To RT Wang 2000 Atrophy and intestinal metaplasia one year after cure of H. pylori infection: A prospective, randomized study Gastroenterology 119 7-14 10889149 10.1053/ gast.2000.8550 1:STN:280:DC%2BD3czkvFCjug%3D%3D
42. P Correa ET Fontham JC Bravo LE Bravo B Ruiz G Zarama 2000 Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti- Helicobacter pylori therapy J Natl Cancer Inst 92 1881-8 11106679 10.1093/jnci/92.23.1881 1:CAS:528:DC%2BD3cXptVehu7s%3D
43. N Kim SH Lim KH Lee SE Choi HC Jung IS Song 2000 Long-term effects of Helicobacter pylori eradication on intestinal metaplasia in patients with duodenal and benign gastric ulcers Dig Dis Sci 45 1754-62 11052316 10.1023/A:1005534328511 1:STN:280:DC%2BD3crgtlOltA%3D%3D
44. PI Hsu KH Lai HH Tseng CK Lin GH Lo JS Cheng 2000 Impact of Helicobacter pylori eradication on the development of MALT, gland atrophy and intestinal metaplasia of the antrum Zhonghua Yi Xue Za Zhi (Taipei) 63 279-87 1:STN:280:DC%2BD3c3otVGnsw%3D%3D
45. T Ohkusa K Fujiki I Takashimizu J Kumagai T Tanizawa Y Eishi 2001 Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated Ann Intern Med 134 380-6 11242498 1:STN:280:DC%2BD3M7lt1ehtw%3D%3D
46. B Ruiz J Garay P Correa ET Fontham JC Bravo LE Bravo 2001 Morphometric evaluation of gastric antral atrophy: Improvement after cure of Helicobacter pylori infection Am J Gastroenterol 96 3281-7 11774937 10.1111/j.1572-0241.2001.05326.x 1:STN:280:DC%2BD38%2FkslaqtQ%3D%3D
47. A Kokkola P Sipponen H Rautelin M Harkonen TU Kosunen R Haapiainen 2002 The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia Aliment Pharmacol Ther 16 515-20 11876705 10.1046/j.1365-2036.2002.01214.x 1:STN:280:DC%2BD387nvVSlsA%3D%3D
48. M Ito K Haruma T Kamada M Mihara S Kim Y Kitadai 2002 Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: A 5-year prospective study of patients with atrophic gastritis Aliment Pharmacol Ther 16 1449-56 12182744 10.1046/ j.1365-2036.2002.01311.x 1:CAS:528:DC%2BD38XnsVSktrY%3D
49. L Zhou JJ Sung S Lin Z Jin S Ding X Huang 2003 A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication Chin Med J (Engl) 116 11-4
50. T Kamada K Haruma J Hata H Kusunoki A Sasaki M Ito 2003 The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis Aliment Pharmacol Ther 18 245-52 12869086 10.1046/j.1365-2036.2003.01669.x 1:STN:280:DC%2BD3szjs1yntQ%3D%3D
51. WK Leung SR Lin JY Ching KF To EK Ng FK Chan 2004 Factors predicting progression of gastric intestinal metaplasia: Results of a randomised trial on Helicobacter pylori eradication Gut 53 1244-9 15306578 10.1136/ gut.2003.034629 1:STN:280:DC%2BD2cvgt1Cmuw%3D%3D
52. C Ley A Mohar J Guarner R Herrera-Goepfert LS Figueroa D Halperin 2004 Helicobacter pylori eradication and gastric preneoplastic conditions: A randomized, double-blind, placebo-controlled trial Cancer Epidemiol Biomarkers Prev 13 4-10 14744726 10.1158/1055-9965.EPI-03-0124 1:CAS:528:DC%2BD2cXmsVWgtQ%3D%3D
53. EJ Kuipers GF Nelis EC Klinkenberg-Knol P Snel D Goldfain JJ Kolkman 2004 Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: Results of a randomised controlled trial Gut 53 12-20 14684569 10.1136/gut.53.1.12 1:CAS:528:DC%2BD2cXptlKrtA%3D%3D
54. R Mera ET Fontham LE Bravo JC Bravo MB Piazuelo MC Camargo 2005 Long term follow up of patients treated for Helicobacter pylori infection Gut 54 1536-40 15985559 10.1136/gut.2005.072009 1:STN:280:DC%2BD2MrltVejtA%3D%3D
55. MF Dixon 2001 Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia Gut 49 2-4 11413099 10.1136/gut.49.1.2 1:STN:280:DC%2BD3MzkvFOnsw%3D%3D
56. BC Wong SK Lam WM Wong JS Chen TT Zheng RE Feng 2004 Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: A randomized controlled trial JAMA 291 187-94 14722144 10.1001/ jama.291.2.187 1:CAS:528:DC%2BD2cXkvVCjuw%3D%3D
57. S Take M Mizuno K Ishiki Y Nagahara T Yoshida K Yokota 2005 The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease Am J Gastroenterol 100 1037-42 15842576 10.1111/j.1572-0241.2005.41384.x
58. K Nozaki N Shimizu Y Ikehara M Inoue T Tsukamoto K Inada 2003 Effect of early eradication on Helicobacter pylori -related gastric carcinogenesis in Mongolian gerbils Cancer Sci 94 235-9 12824915 10.1111/ j.1349-7006.2003.tb01426.x 1:CAS:528:DC%2BD3sXktVCqs7g%3D
59. X Cai J Carlson C Stoicov H Li TC Wang J Houghton 2005 Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice Gastroenterology 128 1937-52 15940628 10.1053/j.gastro.2005.02.066 1:CAS:528:DC%2BD2MXlvFKlsbg%3D
60. P Michetti AM Svennerholm 2003 Helicobacter pylori - inflammation, immunity and vaccines Helicobacter 8 Suppl 1 31-5 14617215 10.1046/ j.1523-5378.2003.00164.x 1:CAS:528:DC%2BD3sXpsVSkt7g%3D